3M Company (MMM) 157.21 $MMM Dow 30 Stock Roundup:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
3M Company (MMM) 157.21 $MMM

Dow 30 Stock Roundup: Apple, Pfizer Results Impress, Microsoft, Merck Beat on Earnings
Swarup Gupta - Zacks Investment Research - Fri Oct 30, 12:58PM CDT
A combination of factors ensured that the Dow had to suffer a relatively disappointing week.
KO: 42.35 (-0.44), MMM: 157.21 (-0.40), VRX: 93.77 (-17.73), PFE: 33.82 (-0.95), BA: 148.07 (+0.89), CCE: 51.34 (+0.22), AGN: 308.47 (+4.09), IBM: 140.08 (-0.47), MRK: 54.66 (-0.21), DD: 63.40 (+0.06), GOOGL: 737.39 (-7.46), PG: 76.38 (-0.64), MSFT: 52.64 (-0.72), AAPL: 119.50 (-1.03)

5 Stocks to Ride October's Rebound
Swarup Gupta - Zacks Investment Research - Mon Oct 26, 1:51PM CDT
Following August's market rout and another slump in September, stocks have staged a dramatic comeback in October.
MMM: 157.21 (-0.40), HA: 34.70 (-0.06), GIG: 2.48 (+0.23), EDU: 27.51 (-0.22), AMRK: 14.50 (+0.68), CAT: 72.99 (+1.02), UFPI: 72.63 (-1.01)

3M Novec 7100 Fluid Used in World's Largest Two-Phase Immersion Cooling Project
Business Wire - Mon Oct 26, 10:19AM CDT
The world's most powerful two-phase immersion cooling (2PIC) project, which will be deployed in a 40+ MW data center being constructed by BitFury Group, is currently underway in the Republic of Georgia. Designed and built by the Hong Kong-based engineering company, Allied Control, the 2PIC project will use 3M(TM) Novec(TM) 7100 Engineered Fluid, an immersion coolant with a low global warming potential. Allied Control is a pioneer in 2PIC, a field showing great promise in boosting data center efficiency.
MMM: 157.21 (-0.40)

3M (MMM) Stock Price Target Raised at Deutsche Bank
at The Street - Mon Oct 26, 10:10AM CDT
Deutsche Bank raised 3M's (MMM) price target after the company released its third quarter earnings results last week.
MMM: 157.21 (-0.40)

Win or Lose, the Shorts Rule This Market: Jim Cramer's Best Blogs
at The Street - Fri Oct 23, 8:00PM CDT
Catch up on Jim Cramer's ideas from this past week as he discusses the unprecedented power of the short sellers to determine pricing today -- even when they bet wrong.
KO: 42.35 (-0.44), KMI: 27.35 (+0.15), MMM: 157.21 (-0.40), VRX: 93.77 (-17.73), GE: 28.92 (-0.42), CLX: 121.94 (-0.78), SWKS: 77.24 (+2.61), DAL: 50.84 (+0.34), UTX: 98.41 (-0.64), KMB: 119.71 (-2.06), CYH: 28.04 (-0.74), NXPI: 78.35 (+5.35), BA: 148.07 (+0.89), HRZN: 9.76 (+0.12), PEP: 102.19 (-0.61), AGN: 308.47 (+4.09), HCA: 68.79 (+1.09), JPM: 64.25 (-0.96), MCD: 112.25 (-0.37), AVGO: 123.13 (+3.04)

Rising Dollar Means Stronger Headwinds For U.S. Firms
at Investor's Business Daily - Fri Oct 23, 1:34PM CDT
China on Friday cut interest rates for the sixth time since November, trying to revive flagging growth. On Thursday, European Central Bank President Mario Draghi gave strong indications that the ECB would boost stimulus efforts in December. The...
MMM: 157.21 (-0.40), GE: 28.92 (-0.42), MCD: 112.25 (-0.37), GOOGL: 737.39 (-7.46), PG: 76.38 (-0.64)

Better-than-Expected Q3 Earnings Lift Industrial ETFs
Zacks Equity Research - Zacks Investment Research - Fri Oct 23, 10:49AM CDT
The upward movement in major industrial stocks since their earnings release caused the shares of industrial ETFs to trade in the green.
IYJ: 105.20 (+0.15), MMM: 157.21 (-0.40), GE: 28.92 (-0.42), HON: 103.28 (+0.34), XLI: 54.27 (-0.07), CAT: 72.99 (+1.02), VIS: 103.25 (-0.16), UNP: 89.35 (-1.17)

Dow 30 Stock Roundup: 3M, Boeing, GE Beat on Earnings, American Express Misses Estimates
Swarup Gupta - Zacks Investment Research - Fri Oct 23, 10:39AM CDT
The Dow experienced another mixed week, dominated by tech, biotech and healthcare stocks.
KO: 42.35 (-0.44), MMM: 157.21 (-0.40), GE: 28.92 (-0.42), VRX: 93.77 (-17.73), AXP: 73.26 (-0.96), IBM: 140.08 (-0.47), UTX: 98.41 (-0.64), MCD: 112.25 (-0.37), CAT: 72.99 (+1.02), BA: 148.07 (+0.89), VZ: 46.88 (+0.48), TRV: 112.89 (-1.40)

3M Stock Is Poised to Move Lower -- Here's How to Profit With Options
at The Street - Fri Oct 23, 10:20AM CDT
3M (MMM) stock's rally in the wake of earnings is probably exaggerated. Here's how to use options to profit from the coming correction.
MMM: 157.21 (-0.40)

Stock Market News for October 23, 2015
Zacks Equity Research - Zacks Investment Research - Fri Oct 23, 9:10AM CDT
Benchmarks ended higher on Thursday banking on ECB’s indication to extend stimulus measures, positive earnings results and upbeat economic data
MMM: 157.21 (-0.40), GE: 28.92 (-0.42), EBAY: 27.90 (-0.27), HON: 103.28 (+0.34), MCD: 112.25 (-0.37), CAT: 72.99 (+1.02), BA: 148.07 (+0.89), DOW: 51.67 (+0.77), UNP: 89.35 (-1.17)

3M (MMM) Stock Price Target Hiked at Barclays Following Earnings Results
at The Street - Fri Oct 23, 9:03AM CDT
3M's (MMM) price target was increased to $150 from $135 at Barclays on Friday, after the company reported 2015 third quarter earnings that were ahead of expectations.
MMM: 157.21 (-0.40)

3M to restructure, cut 1,500
at Investor's Business Daily - Thu Oct 22, 6:16PM CDT
3M (MMM) launched a restructuring program that includes cutting 1,500 jobs and trimmed its full-year EPS outlook to $7.73-$7.78 from $7.73-$7.93 vs. views for $7.77. Q3 EPS rose 3.5% to $2.05, topping by 5 cents. Revenue fell 5.3% to $7.71 bil,...
MMM: 157.21 (-0.40), CAT: 72.99 (+1.02)

Stocks Rise 1%, Led By McDonald's, Other Bellwethers
at Investor's Business Daily - Thu Oct 22, 4:01PM CDT
The major averages rose more than 1% Thursday, closing near their intraday highs, following strong earnings reports from a number of market bellwethers. The Dow Jones industrial average jumped 1.9%, as McDonald's (MCD) and 3M (MMM) soared following...
MMM: 157.21 (-0.40), MCD: 112.25 (-0.37)

3M Rises 4.12% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Oct 22, 3:59PM CDT
3M (NYSE:MMM) traded in a range yesterday that spanned from a low of $150.65 to a high of $157.04. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $151.39 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MMM: 157.21 (-0.40)

3M Set to Possibly Pullback After Yesterday's Rally of 4.12%
Comtex SmarTrend(R) - Thu Oct 22, 3:59PM CDT
3M (NYSE:MMM) traded in a range yesterday that spanned from a low of $150.65 to a high of $157.04. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $151.39 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MMM: 157.21 (-0.40)

3M Company (MMM) Earnings Report: Q3 2015 Conference Call Transcript
at The Street - Thu Oct 22, 3:35PM CDT
The following 3M Company (MMM) conference call took place on October 22, 2015, 09:00 AM ET. This is a transcript of that earnings call:
MMM: 157.21 (-0.40)

3M Joins Caterpillar In Restructuring As Dow Gains
at Investor's Business Daily - Thu Oct 22, 3:31PM CDT
Industrial giant 3M (MMM) launched a restructuring program that includes cutting 1,500 positions globally, joining Caterpillar (CAT) as it adapts to weaker overseas growth, while Dow Chemical (DOW) reported strong earnings. St. Paul, Minn.-based 3M...
MMM: 157.21 (-0.40), CAT: 72.99 (+1.02), DOW: 51.67 (+0.77)

3M Company (MMM) Beats on Q3 Earnings, Revenues Down Y/Y
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 1:45PM CDT
3M Company (MMM) reported earnings of $2.05 per share for third-quarter 2015, beating the Zacks Consensus Estimate of $2.01 and reflecting an increase of 3.5% year over year.
MMM: 157.21 (-0.40), CODI: 16.45 (-0.20), GHM: 16.97 (+0.11), DHR: 93.31 (+0.27)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 241

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 80

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 373

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading